Strung
This jewelry company may string you along.
XanRelax and Addall
Case Name (Date)
Brown et al. v. ZMB Enterprises LLC
22-cv-54, S.D. Cal.
(Jan. 2022)
Product/Service
XanRelax and Addall
Allegations
Misleadingly labeling products as “dietary supplements” when they contain illegal ingredients and thus do not meet the definition of “dietary supplement” under federal law
Misleadingly using the name XanRelax to make consumers believe the product provides benefits similar to the prescription drug Xanax
Misleadingly using the name Addall to make consumers believe the product provides benefits similar to the prescription drug Adderall
Falsely marketing products as able to treat, cure, and prevent diseases, including depression, anxiety, and ADHD, and without FDA approval to do so
Status
Pending
The Latest
Best Reader Tips of 2025
Consumer complaints worth remembering.
How Marketers Trick Kids, and Why Parents Should Worry
Herb Weisbaum, Consumers’ Checkbook
Saatva
TINA.org pulls back the covers on this company’s Made in USA marketing.
Monetizing Minors: Eric Befumo (aka Big Justice)
Brand partnerships worthy of a big “doom!”